1. Home
  2. RVMD vs AXON Comparison

RVMD vs AXON Comparison

Compare RVMD & AXON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$161.65

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Axon Enterprise Inc.

AXON

Axon Enterprise Inc.

HOLD

Current Price

$418.03

Market Cap

33.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
AXON
Founded
2014
1993
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
33.2B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
RVMD
AXON
Price
$161.65
$418.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
16
Target Price
$140.84
$758.80
AVG Volume (30 Days)
2.5M
1.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$2,779,536,000.00
Revenue This Year
N/A
$31.50
Revenue Next Year
$533.02
$28.95
P/E Ratio
N/A
$204.61
Revenue Growth
N/A
33.47
52 Week Low
$34.00
$339.01
52 Week High
$166.50
$885.92

Technical Indicators

Market Signals
Indicator
RVMD
AXON
Relative Strength Index (RSI) 61.78 45.75
Support Level $141.22 $403.48
Resistance Level $166.50 $587.37
Average True Range (ATR) 6.70 28.33
MACD 0.20 -5.72
Stochastic Oscillator 85.99 18.80

Price Performance

Historical Comparison
RVMD
AXON

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About AXON Axon Enterprise Inc.

Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.

Share on Social Networks: